K Chandrasekhar, Founder & CEO, Forus Health underlined that 3nethra NEO is a result of consistent efforts & clinical trials

Forus Health Private Limited, a Bengaluru-based medical devices company focused on developing state-of-the-art ophthalmic devices, has announced the launch of 3nethra NEO, which is a Retinopathy of Prematurity (ROP) imaging platform.

Forus Health – Overview  

Founded in 2010, Forus Health aims to eradicate preventable blindness using technology. It has successfully deployed thousands of its flagship adult retinal imaging device “ 3nethra classic in 25 countries.

Dr Shyam Vasudeva Rao ,Founder & Director Forus Health along with K Chandrasekhar highlighted the key features of 3nethra NEO

Understanding Retinopathy of Prematurity (ROP)

• The leading cause of blindness in infants in the world.
• In India, one out of three babies born less than 2,000 grams develops the disease and 10 percent of the babies will turn blind at the age of 2 months if not treated on time.
• Annually, over 3.5 million babies are born premature in India.
• Less than 100 ROP specialists nationwide to screen & treat this condition.

3nethra neo is the most affordable ROP imaging device with an integrated telemedicine platform that helps in remote diagnosis

3nethra NEO “ Key Takeaways

• Result of consistent efforts to build affordable & state-of-the-art imaging solutions for eye care.
• One of solutions of collaboration with Narayana Nethralaya for clinical trials.
• Most affordable ROP imaging device with an integrated telemedicine platform that helps in remote diagnosis.
• The device costs one fourth of its nearest competitor.
• Quality was found to be at par with the imported cameras during clinical trials.
• Found to be useful for telemedicine settings during clinical trials under Narayana Nethralayas KIDROP outreach programme

3nethra NEO “ Key Features

• Has four design patents for this product to protect design.
• A light weight & compact wide-angle imaging device.
• Its skillfully designed optics, ergonomic natural grip for easy holding & high reliability enhanced by a unique focusing and illumination system makes it an ideal choice for neonatal ICUs.

Understanding  the Karnataka Internet Assisted Diagnosis of Retinopathy of Prematurity (KIDROP) Programme

• In 2007, Narayana Nethralaya pioneered an ROP screening programme called KIDROP.
• Screens premature infants in rural areas & detects and treats this condition using a unique telemedicine model.
• It is currently the worlds largest tele-ROP programme that serves over 102 rural units.
• Cited by the United Nations Development Programme (UNDP), Niti Ayog or the National Institution for Transforming India, Harvard Business Review, IIM-A, IIM-B and been validated by the CDC Atlanta guidelines.
• In June 2016, KIDROP was awarded the National Award for HealthCare Excellence for Rural Outreach.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.